Moving average and standard deviation thresholding (MAST): a novel algorithm for accurate R-wave detection in the murine electrocardiogram.

Advances in implantable radio-telemetry or diverse biologging devices capable of acquiring high-resolution ambulatory electrocardiogram (ECG) or heart rate recordings facilitate comparative physiological investigations by enabling detailed analysis of cardiopulmonary phenotypes and responses in vivo. Two priorities guiding the meaningful adoption of such technologies are: (1) automation, to streamline and standardize large dataset analysis, and (2) flexibility in quality-control. The latter is especially relevant when considering the tendency of some fully automated software solutions to significantly underestimate heart rate when raw signals contain high-amplitude noise. We present herein moving average and standard deviation thresholding (MAST), a novel, open-access algorithm developed to perform automated, accurate, and noise-robust single-channel R-wave detection from ECG obtained in chronically instrumented mice. MAST additionally and automatically excludes and annotates segments where R-wave detection is not possible due to artefact levels exceeding signal levels. Customizable settings (e.g. window width of moving average) allow for MAST to be scaled for use in non-murine species. Two expert reviewers compared MAST's performance (true/false positive and false negative detections) with that of a commercial ECG analysis program. Both approaches were applied blindly to the same random selection of 270 3-min ECG recordings from a dataset containing varying amounts of signal artefact. MAST exhibited roughly one quarter the error rate of the commercial software and accurately detected R-waves with greater consistency and virtually no false positives (sensitivity, Se: 98.48% ± 4.32% vs. 94.59% ± 17.52%, positive predictivity, +P: 99.99% ± 0.06% vs. 99.57% ± 3.91%, P < 0.001 and P = 0.0274 respectively, Wilcoxon signed rank; values are mean ± SD). Our novel, open-access approach for automated single-channel R-wave detection enables investigators to study murine heart rate indices with greater accuracy and less effort. It also provides a foundational code for translation to other mammals, ectothermic vertebrates, and birds.

Improved electromagnetic tracking for catheter path reconstruction with application in high-dose-rate brachytherapy.

PURPOSE: Electromagnetic (EM) catheter tracking has recently been introduced in order to enable prompt and uncomplicated reconstruction of catheter paths in various clinical interventions. However, EM tracking is prone to measurement errors which can compromise the outcome of the procedure. Minimizing catheter tracking errors is therefore paramount to improve the path reconstruction accuracy. METHODS: An extended Kalman filter (EKF) was employed to combine the nonlinear kinematic model of an EM sensor inside the catheter, with both its position and orientation measurements. The formulation of the kinematic model was based on the nonholonomic motion constraints of the EM sensor inside the catheter. Experimental verification was carried out in a clinical HDR suite. Ten catheters were inserted with mean curvatures varying from 0 to [Formula: see text] in a phantom. A miniaturized Ascension (Burlington, Vermont, USA) trakSTAR EM sensor (model 55) was threaded within each catheter at various speeds ranging from 7.4 to [Formula: see text]. The nonholonomic EKF was applied on the tracking data in order to statistically improve the EM tracking accuracy. A sample reconstruction error was defined at each point as the Euclidean distance between the estimated EM measurement and its corresponding ground truth. A path reconstruction accuracy was defined as the root mean square of the sample reconstruction errors, while the path reconstruction precision was defined as the standard deviation of these sample reconstruction errors. The impacts of sensor velocity and path curvature on the nonholonomic EKF method were determined. Finally, the nonholonomic EKF catheter path reconstructions were compared with the reconstructions provided by the manufacturer's filters under default settings, namely the AC wide notch and the DC adaptive filter. RESULTS: With a path reconstruction accuracy of 1.9 mm, the nonholonomic EKF surpassed the performance of the manufacturer's filters (2.4 mm) by 21% and the raw EM measurements (3.5 mm) by 46%. Similarly, with a path reconstruction precision of 0.8 mm, the nonholonomic EKF surpassed the performance of the manufacturer's filters (1.0 mm) by 20% and the raw EM measurements (1.7 mm) by 53%. Path reconstruction accuracies did not follow an apparent trend when varying the path curvature and sensor velocity; instead, reconstruction accuracies were predominantly impacted by the position of the EM field transmitter ([Formula: see text]). CONCLUSION: The advanced nonholonomic EKF is effective in reducing EM measurement errors when reconstructing catheter paths, is robust to path curvature and sensor speed, and runs in real time. Our approach is promising for a plurality of clinical procedures requiring catheter reconstructions, such as cardiovascular interventions, pulmonary applications (Bender et al. in medical image computing and computer-assisted intervention-MICCAI 99. Springer, Berlin, pp 981-989, 1999), and brachytherapy.

Electromagnetic tracking in surgical and interventional environments: usability study.

PURPOSE: Electromagnetic (EM) tracking of instruments within a clinical setting is notorious for fluctuating measurement performance. Position location measurement uncertainty of an EM system was characterized in various environments, including control, clinical, cone beam computed tomography (CBCT), and CT scanner environments. Static and dynamic effects of CBCT and CT scanning on EM tracking were evaluated. METHODS: Two guidance devices were designed to solely translate or rotate the sensor in a non-interfering fit to decouple pose-dependent tracking uncertainties. These devices were mounted on a base to allow consistent and repeatable tests when changing environments. Using this method, position and orientation measurement accuracies, precision, and 95 % confidence intervals were assessed. RESULTS: The tracking performance varied significantly as a function of the environment-especially within the CBCT and CT scanners-and sensor pose. In fact, at a fixed sensor position in the clinical environment, the measurement error varied from 0.2 to 2.2 mm depending on sensor orientations. Improved accuracies were observed along the vertical axis of the field generator. Calibration of the measurements improved tracking performance in the CT environment by 50-85 %. CONCLUSION: EM tracking can provide effective assistance to surgeons or interventional radiologists during procedures performed in a clinical or CBCT environment. Applications in the CT scanner demand precalibration to provide acceptable performance.

Heart rate variability and procedural outcome in catheter ablation for atrial fibrillation.

INTRODUCTION: In patients with normal hearts, increased vagal tone is associated with onset of paroxysmal atrial fibrillation (AF). Vagal denervation of the atria renders AF less inducible. Circumferential pulmonary vein isolation (CPVI) is effective for treating paroxysmal and persistent AF, and has been shown to impact heart rate variability (HRV) indices, in turn, reflecting vagal denervation. We examined the impact of CPVI on HRV indices, and evaluated the relationship between vagal modification and AF recurrence. METHODS: Electrocardiogram recordings were collected from 83 consecutive patients (63 male, 20 female, age 56.9 ± 9.3 years) undergoing CPVI for paroxysmal (n = 56) or persistent (n = 27) AF. Recordings were obtained over 10 minutes preprocedure, and at intervals up to 12 months. Antiarrhythmic medications were suspended prior to CPVI, and were resumed for 3 months following. Success was defined as no recurrence of atrial arrhythmia lasting longer than 30 seconds. RESULTS: In patients with successful procedures (n = 56, 42 paroxysmal, 14 persistent), HRV indices were significantly altered, with respect to preprocedure levels, over a sustained period. However, patients with recurrence (n = 27, 14 paroxysmal, 13 persistent) demonstrated similar HRV to their preprocedure levels over the follow-up period. CONCLUSION: Our results suggest that patients experiencing recurrence after a single CPVI have HRV attenuated by the procedure only intermittently, whereas patients with one successful CPVI experience a sustained change. A short-term HRV recording is a convenient and potentially important marker for recurrence of atrial arrhythmia in a population undergoing CPVI.

Validation of a novel algorithm for quantification of the percentage of signal fractionation in atrial fibrillation.

AIMS: Catheter ablation for paroxysmal atrial fibrillation (AF) is rapidly becoming a standard practice. There is literature to support that catheter ablation of persistent AF requires additional 'substrate modification'. In clinical practice, operators rely on automated fractionation maps created by three-dimensional anatomic mapping systems to rapidly assess complex 'fractionated' signals (CFAE). These systems use differing algorithms to automate the process. The agreement between operators and contemporary algorithms has not been examined. We sought to assess the agreement between operators and a novel method of quantification calculating percentage fractionation (PF). METHODS AND RESULTS: Expert opinion on 80 atrial electrogram 4 s signals of varying levels of activity were gathered and pooled for comparison. Twelve independent experts visually quantified the signal fractionation and offered a threshold level for ablation. We developed an algorithm to find sites with high continuous electrical activity, or high PF. Correlation between experts and PF was 0.78 [P < 0.01, 95% confidence interval (CI) (0.68-0.86)]. Receiver operating characteristics curve sensitivity and specificity for PF were 0.7727 and 0.8103 at the optimal cut-off point of 58.45 PF with area under curve 0.89 CI (0.80-0.99). CONCLUSION: The PF statistic represents a more robust and intuitive measure to represent fractionated atrial activity; importantly it demonstrates excellent agreement with expert users and presents a new standard for algorithm assessment. Use of a PF statistic should be considered in automated mapping systems.

Multi-lead QRS detection using window pairs.

We designed a novel approach for multi-lead QRS detection. The algorithm uses one equation with two different window widths to generate a feature signal and a detection threshold. This enables it to adapt to various changes in QRS morphology and noise levels, resulting in a detection error rate of just 0.29% on the MIT-BIH Arrhythmia Database. The algorithm is also computationally efficient and capable of resolving differences between multiple leads by automatically attaching a confidence value to each QRS detection.

Perfil autonómico de los pacientes derivados a una clínica de trastornosdel sueño: impacto de la CPAPen el sistema nervioso autónomo / Autonomic profile of patients referred to a sleep disorder clinic: impact of CPAP on the autonomic nervous system

Introducción: la apnea obstructiva del sueño (AOS) severa ha sido asociada con disfunción autonómica. La presión positiva continua en la vía aérea (CPAP) es el tratamiento estándar para la AOS, aun cuando su impacto sobre la disfunción autonómica no haya sido plenamente investigado. La variabilidad de la frecuencia cardíaca (VFC) es una técnica cuantitativa no invasiva para la evaluación de la actividad autonómica. Nuestro objetivo fue determinar si los pacientes con AOS severa presentan niveles mayores de disfunción autonómica que los pacientes con un índice de apnea-hipopnea (IAH) normal, y si la CPAP mejora los parámetros de VFC a la vez que mejora el IAH.Métodos: todos los pacientes fueron sometidos a una polisomnografía (PSG) completa en una clínica de trastornos del sueño. Se definió como severa a una AOS que tuviera un IAH ³ 30 (eventos por hora), y se definió al grupo control como aquellos que tuvieran un IAH < 5. Se calculó la VFC antes y después de la CPAP, analizando trazados electrocardiogáficos de 10 minutos, conforme las pautas de normalización. Los pacientes con AOS severa fueron tratados con CPAP durante un período de 4-6 semanas (titulados durante la polisomnografía), y los pacientes control no recibieron ninguna intervención entre sus dos registros de electrocardiograma (ECG).Resultados: el estudio incluyó a un total de 20 pacientes con AOS severa y 10 controles. En los pacientes con AOS severa, el IAH se redujo al utilizar CPAP de 38,0 ± 11,0 a 23,0 ± 11,0 (p<0,01). Aparte de una diferencia significativa en el índice de masa corporl (IMC) entre los paciente con AOS y los controles (35,3±4,7 versus 26,6±4,6 kg/m2, p<0,01), los grupos fueron comparables en cuanto a edad, condición de hipertensión y género. No hubo ninguna diferencia significativa (p<0,05) en ningún parámetro de VFC entre los pacientes con AOS severa y los controles, ni entre los pacientes con AOS antes y después de CPAP (tabla 2).

Introduction: severe obstructive sleep apnea (OSA) has been associated with autonomic dysfunction. Continuous positive airway pressure (CPAP) is standard treatment for OSA, although its impact on autonomic dysfunction was not fully investigated. Heart rate variability (HRV) is a non-invasive quantitative technique for assessment of autonomic activity. We aimed to determine if patients with severe OSA exhibit greater levels of autonomic dysfunction than patients with normal apnea-hypopnea index (AHI), and if CPAP improves heart rate variability (HRV) parameters while improving AHI.Methods: all patients underwent full polysomnography (PSG) at a Sleep Disorder Clinic. Severe OSA was defined as AHI ³ 30 (events per hour), and control was defined as AHI < 5. HRV was calculated pre and post-CPAP from a 10-minute electrocardiogram (ECG) recording in accordance with guidelines for standardization. Patients with severe OSA were treated with CPAP for a period of 4-6 weeks (titrated during PSG), and control patients underwent no intervention between their two ECG recordings.Results: a total of 20 patients with severe OSA and 10 controls were included (Table 1). In patients with severe OSA, AHI was reduced by CPAP from 38.0 ± 11.0 to 23.0 ± 11.0 (P<0.01). Aside from a significant difference in BMI between OSA patients and controls (35.3±4.7 vs. 26.6±4.6 kg/m2, P<0.01), groups were comparable in age, hypertension, and gender. There was no significant difference (P<0.05) in any HRV parameters between patients with severe OSA and controls, and between OSA patients pre- and post-CPAP (table 2).